Healthcare

New Delhi: Pharmaceutical companies awaiting report on the safety of those fixed dose combinations (FDCs) that were earlier banned by the ministry of health and family welfare are unlikely to get a breather. The expert panel probing the efficacy of 349 (344+5) banned FDCs is likely to reinforce the ban. According to the people with knowledge of the development,...

Her name is Cherry and she is the smallest baby ever born in India. At birth, she was just about 26 cms in length – that is about the size of your palm — and weighed 375 grams, making her perhaps the smallest not just in India but in the whole of South Asia. Normally, babies...

Hyderabad-based Aurobindo Pharma has inked a definitive agreement with Canadian pharmaceutical firm Apotex to take over its commercial operations in five European countries. The two pharma players signed an all-cash deal amounting to 74 million euros, under which Aurobindo’s step-down subsidiary Agile Pharma B V will acquire commercial businesses of Apotex and some supporting infrastructure, according to a...

New Delhi: DUSA Pharmaceuticals, a unit of Sun Pharmaceutical Industries, has filed a trade secret misappropriation and tortious interference claim against Biofrontera Inc. in the district court of Massachusetts, the company said in a statement. The lawsuit alleges patent violation of topical solution Levulan, and Kerastick. DUSA has also alleged that the Germany-based Biofrontera improperly obtained confidential information from...

Cadila Healthcare share price erased opening gains after rising more than a percent due to tentative approval from the US health regulator for the oral iron chelator. The company in its filing said its group company Zydus has received tentative approval from the US Food and Drug Administration for Deferasirox. Cadila Healthcare stock erases opening gains, Zydus gets...

China said on Monday it had reached an agreement with India to reduce tariffs and increase imports of Indian medicines, particularly anti-cancer drugs, part of moves to broaden its trade relations amid its on-going spat with the United States. Both India and China slashed import tariffs of a range of products starting July 1, following the fourth round...

Share price of Dr Reddy’s Laboratories added 3 percent intraday Monday as company entered in to distribution and co-promotion agreement with UCB. The company has entered into a distribution and co-promotion agreement with UCB for Briviact, a brand of brivaracetam. The agreement grants company the exclusive right to distribute Briviact in India. Briviact is approved as an adjunctive therapy for...

For Immediate Release Mumbai, 2018: A brainchild of Dr. Atish Laddad, The Pediatric Network (TPN) is an alternative child health support program that aims to acquire a holistic healthcare and wellbeing for every child. Its chief objective has always been to bestow children across India with a healthy and sheltered lifestyle by making positive alterations and advancements in the...

Bengaluru: Britain’s Indivior PLC fell by more than 20% on Friday after the US Food and Drug Administration (FDA) approved the first generic versions of Suboxone Film, an opioid addiction treatment that generates 80% of its revenue. Dr Reddy’s Laboratories received FDA approval for a copy-cat version of the treatment, which has been rapidly losing market share due to...

New Delhi: The quality cloud over the Halol plant of Sun Pharmaceutical Industries Ltd has lifted, with the company stating that all the issues raised by the US Food and Drug Administration (FDA) have been satisfactorily resolved. “Sun Pharmaceutical Industries has received the establishment inspection report (EIR) from the US FDA for the inspection conducted at its Halol facility...